PFE dividend yield: 6.77%. K dividend yield: 4.00%. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity. K is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in K shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
K is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in K shares.
PFE currently offers a 6.77% yield (1.68/share/year) while K offers 4.00% (2.00/share/year). PFE provides higher current income. However, K has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in PFE vs K earn per year?
With $10,000 invested today: PFE pays approximately $677/year. K pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $5,820/year (PFE) and $899/year (K).
Does PFE or K pay monthly dividends?
PFE pays quarterly dividends. K pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this PFE vs K comparison by email
Save your analysis + get weekly dividend insights. Free forever.